1. A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy. (20th December 2018) Authors: Osaki, Akihiko; Inoue, Kenichi; Sakai, Hiroshi; Yamada, Kazuhiko; Minato, Koichi; Ohyanagi, Fumiyoshi; Tokuda, Yutaka; Ikeda, Norihiko; Kagamu, Hiroshi; Kubota, Kaoru; Tamura, Tomohide; Saeki, Toshiaki Journal: Japanese journal of clinical oncology Issue: Volume 49:Number 2(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. (December 2019) Authors: Hida, Toyoaki; Velcheti, Vamsidhar; Reckamp, Karen L.; Nokihara, Hiroshi; Sachdev, Pallavi; Kubota, Tomoki; Nakada, Takuya; Dutcus, Corina E.; Ren, Min; Tamura, Tomohide Journal: Lung cancer Issue: Volume 138(2019) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC. Issue 8 (19th January 2022) Authors: Matsuura, Kazuo; Tsurutani, Junji; Inoue, Kenichi; Tanabe, Yuko; Taira, Tetsuhiko; Kubota, Kaoru; Tamura, Tomohide; Saeki, Toshiaki Journal: Cancer Issue: Volume 128:Issue 8(2022) Page Start: 1692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy. (September 2016) Authors: Yoh, Kiyotaka; Hosomi, Yukio; Kasahara, Kazuo; Yamada, Kazuhiko; Takahashi, Toshiaki; Yamamoto, Nobuyuki; Nishio, Makoto; Ohe, Yuichiro; Koue, Toshiko; Nakamura, Takashi; Enatsu, Sotaro; Lee, Pablo; Ferry, David; Tamura, Tomohide; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 99(2016) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Issue 10089 (1st July 2017) Authors: Hida, Toyoaki; Nokihara, Hiroshi; Kondo, Masashi; Kim, Young Hak; Azuma, Koichi; Seto, Takashi; Takiguchi, Yuichi; Nishio, Makoto; Yoshioka, Hiroshige; Imamura, Fumio; Hotta, Katsuyuki; Watanabe, Satoshi; Goto, Koichi; Satouchi, Miyako; Kozuki, Toshiyuki; Shukuya, Takehito; Nakagawa, Kazuhiko; Mi... Journal: Lancet Issue: Volume 390:Issue 10089(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. (July 2018) Authors: Nishio, Makoto; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Yamamoto, Nobuyuki; Tanaka, Tomohiro; Kuriki, Hiroshi; Zeaiter, Ali; Tamura, Tomohide Journal: Lung cancer Issue: Volume 121(2018) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial. Issue 8 (August 2016) Authors: Goto, Koichi; Ohe, Yuichiro; Shibata, Taro; Seto, Takashi; Takahashi, Toshiaki; Nakagawa, Kazuhiko; Tanaka, Hiroshi; Takeda, Koji; Nishio, Makoto; Mori, Kiyoshi; Satouchi, Miyako; Hida, Toyoaki; Yoshimura, Naruo; Kozuki, Toshiyuki; Imamura, Fumio; Kiura, Katsuyuki; Okamoto, Hiroaki; Sawa, Toshiyu... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Congenital pulmonary veno-portal shunt. (29th March 2019) Authors: Kanemura, Hiroaki; Fukuda, Terunobu; Komiyama, Nobuyuki; Tamura, Tomohide; Niwa, Koichiro Journal: European heart journal Issue: Volume 20:Number 9(2019) Page Start: 1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Constrictive pericarditis 20 years after surgical aortic valve replacement. (8th October 2021) Authors: Nishizawa, Toshinori; Ro, Shosei; Asano, Taku; Tamura, Tomohide Journal: Journal of general and family medicine Issue: Volume 23:Number 2(2022) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37–40]. (June 2019) Authors: Nishio, Makoto; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Yamamoto, Nobuyuki; Tanaka, Tomohiro; Kuriki, Hiroshi; Zeaiter, Ali; Tamura, Tomohide Journal: Lung cancer Issue: Volume 132(2019) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗